Background: Hypertrophic scars and keloids result from abnormal healing following trauma or skin procedures. Abnormal scarring can cause aesthetic concerns and physical limitations. There are currently many approaches to minimize the appearance of these scars. The best strategy to treat abnormal scarring is unclear. We resolved to identify the most effective treatment among available, regularly used modalities Methods: A thorough systematic literature review was conducted on leading databases to identify adverse events and standardized mean reduction (SMR) of scars/keloids. Relevant studies included randomized control trials (RCTs) of 20+ patients published on the effectiveness of an accepted treatment for hypertrophic scars and keloids. Results: Of the included clinical trials, SMR was found to differ significantly between given treatments, with adverse events proving rare and dependent upon modality. Physical treatments, like silicone sheeting, (SMR 29.9% ([95% CI, 28.9-30.9%)) and topical treatments (SMR 34% ([95% CI 31.8-36.8%])) were found to be less effective than intralesional injection, which had a SMR of 64.1% ([95% CI 60.8-67.5%]). Within intralesional injection, a 9:1 dilution of combined 5-Fluorouracil (5-FU) and triamcinolone was most effective. Finally, the response to laser treatment was found to be dependent upon a patient’s Fitzpatrick skin type (most effective for types I-III), with ablative and pulsed-dye lasers producing the most improvement for keloids and hypertrophic scars. Conclusions: Our findings suggest there are superior treatment modalities for patients seeking to reduce hypertrophic scars and keloids. Combination intralesional injections were the most efficacious. However, a multifaceted approach would likely yield the best results.